Connect with us

Vaccine

Denmark Suspends Use of AstraZeneca COVID-19 Vaccine

Published

on

New vaccine AstraZeneca isolated on green background-AstraZeneca COVID-19 Vaccine-ss-featured

Denmark, along with Norway and Iceland announced Thursday they will temporarily suspend the use of the AstraZeneca COVID-19 vaccine over concerns over blood clots. The Danish Health Authority said it would temporarily stop as a precaution after receiving reports of “severe cases of blood clots in people ” vaccinated with the AstraZeneca COVID-19 Vaccine.  

News For The Day: House Passes 2 Gun Bills That Expand Background Checks

5 Stocks to Watch Out For Friday, March 12 

Vir Biotechnology Inc ▲(VIR 61.83 USD +15.01 (32.06%)) stocks rocketed out of the gates Thursday. After it announced that its experimental COVID-19 treatment significantly reduced hospitalization and death in high-risk adults. This candidate drug is being developed with partner GlaxoSmithKline. The monoclonal-antibody drug. VIR-7831 reduced death or hospitalization by 85% compared with a placebo in a clinical trial. Following the results, Vir and GSK said they plan to submit an Emergency Use Authorization application. This is a potential game-changer for patients.

Nio Inc – ADR ▲(NIO 46.03 USD +4.71 (11.40%)) stocks jumped more than 11%  after Mizuho initiated coverage, starting with a “Buy” rating and a price target of $60. Nio is touted as a leader in the upscale EV market in China, which in turn, is projected as the largest EV market. Mizuho thinks NIO offers significant upside as it enters the European market later this year and continues with its China forays.

Bumble Inc ▲(BMBL 69.76 USD +6.85 (10.89%)) shares went more than 10% during yesterday’s trading after the company announced it beat its earnings forecast for the quarter. The dating app posted revenue of $165.5 million, squeaking by analyst estimates of $163.3 million.

Novavax, Inc. ▲(NOVA 187.63 USD +15.13 (8.77%)) closed almost 9% during trading hours Thursday, then zoomed 21.62% after hours. The biotech drugmaker reported that recent studies showed that its COVID-19 vaccine is highly effective, notching a 96.4% effective against “mild, moderate, and severe disease caused by the original COVID-19 strain.” Applications for emergency approval are now in the works. 

Vail Resorts, Inc. ▲(MTN 305.48 USD +0.29 (0.095%)) traded much higher after the close, reaching up to 11% before settling in at 9.66%. The ski lodge operator reported a fiscal second-quarter net income of $147.8 million, generating $3.62 earnings per share, handily beating Wall Street estimates of $2.19. Despite being locked down most of last year, Vail’s resorts are now showing signs of life. Season pass sales are going up year over year.

You Might Also Like:

Raven_Steel_Ad-V1
Raven_Steel_Ad-05

Keep up to date with the latest finance news by following us on Facebook and Instagram.

Click to comment

Leave a Reply

Your email address will not be published.

Subscribe To Our Newsletter:



Copyright © 2020 The Capitalist. his copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.

[email]
[email]